drug

Opregen

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Roche

Timeline

Lineage reports Q2 2026 results, advances COR1 corneal program and OpRegen data

Aug 6Quarterly updateLineage Cell Therapeutics, Inc.Opregen

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.